Submit Manuscript  

Article Details


Thromboxane A Synthase: A New Target for the Treatment of Cardiovascular Diseases

Author(s):

Dinara F. Mesitskaya, Abram L. Syrkin, Marina G. Aksenova, Yong Zhang, Andrey A. Zamyatnin* and Philipp Yu. Kopylov*   Pages 1 - 7 ( 7 )

Abstract:


Atherothrombosis-related diseases are one of the world’s leading causes of mortality, and thus the search for new therapeutic approaches in this area remains a very urgent task. Modern pharmacogenomic technologies make it possible to obtain valuable data on disease pathogenesis and optimal therapeutic approaches. One promising research direction is the study of the thromboxane A2 - thromboxane A synthase - thromboxane A2 receptor axis. This review summarizes the recent evidence and suggests that systematic works in this area are creating new and promising opportunities in the treatment of patients with cardiovascular diseases.

Keywords:

thromboxane, thromboxane A synthase, pharmacogenetics, inhibitors of thromboxane A2-synthase.

Affiliation:

Sechenov First Moscow State Medical University, Moscow, Sechenov First Moscow State Medical University, Moscow, Centre for the Strategic Planning and Management of Medical and Biological Health Risks, Moscow, Harbin Medical University, Harbin, Sechenov First Moscow State Medical University, Moscow, Sechenov First Moscow State Medical University, Moscow



Read Full-Text article